Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.07 USD | +0.94% | -6.51% | -21.10% |
Financials (USD)
Sales 2024 * | 274M | Sales 2025 * | 180M | Capitalization | 1.37B |
---|---|---|---|---|---|
Net income 2024 * | -316M | Net income 2025 * | -409M | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | 663M | Net cash position 2025 * | 415M | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
-4.19
x | P/E ratio 2025 * |
-3.33
x | Employees | 577 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.18% |
Latest transcript on Arcus Biosciences, Inc.
1 day | +0.94% | ||
1 week | -6.51% | ||
1 month | -1.05% | ||
3 months | -21.22% | ||
6 months | +0.07% | ||
Current year | -21.10% |
Managers | Title | Age | Since |
---|---|---|---|
Juan Jaen
FOU | Founder | 66 | 14-12-31 |
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Robert Goeltz
DFI | Director of Finance/CFO | 51 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 17-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 69 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 11 M€ | -6.03% | - | |
0.28% | 25 M€ | -2.35% | - | |
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 15.07 | +0.94% | 640,409 |
24-05-30 | 14.93 | -1.45% | 757,265 |
24-05-29 | 15.15 | -3.32% | 470,551 |
24-05-28 | 15.67 | -2.79% | 737,275 |
24-05-24 | 16.12 | -0.98% | 560,498 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.10% | 1.37B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- RCUS Stock